首页> 外国专利> compound, composition, methods for modulating an immune response, for treating and / or preventing disease, for modulating cell uptake and / or clearance, or a portion thereof, for modulating antigen recognition, processing and / or presentation material derived from cells or portions thereof to diagnose, predict and / or monitor the state of a disease, to distinguish between a necrotic cell or dead cell to enrich dendritic cells, or a subset thereof or precursor thereof , and for detecting a cell, uses of the compound and / or composition, dentitic cells or precursor thereof and a polypeptide, compound and composition, vector polynucleotide, host cell, population, and kit

compound, composition, methods for modulating an immune response, for treating and / or preventing disease, for modulating cell uptake and / or clearance, or a portion thereof, for modulating antigen recognition, processing and / or presentation material derived from cells or portions thereof to diagnose, predict and / or monitor the state of a disease, to distinguish between a necrotic cell or dead cell to enrich dendritic cells, or a subset thereof or precursor thereof , and for detecting a cell, uses of the compound and / or composition, dentitic cells or precursor thereof and a polypeptide, compound and composition, vector polynucleotide, host cell, population, and kit

机译:化合物,组合物,用于调节免疫应答,用于治疗和/或预防疾病,用于调节细胞摄取和/或清除的调节方法,或其一部分,用于调节源自细胞或其部分的抗原识别,加工和/或呈递材料的化合物,组合物,方法诊断,预测和/或监测疾病状态,区分坏死细胞或死细胞以丰富树突状细胞或其子集或其前体,以及用于检测细胞,化合物和/或组合物的用途,树突状细胞或其前体以及多肽,化合物和组成,载体多核苷酸,宿主细胞,群体和试剂盒

摘要

The present invention relates to the identification of proteins which bind the dendritic cell marker known as Clec9A. The present invention provides new compounds for targeting therapeutic agents such as antigens to dendritic cells. Also provided are methods of modulating a humoral and/or T cell mediated immune response to the antigen, methods of delivery of a cytotoxic agent to dendritic cells thereof involved in diseased states, methods of modulating the uptake and/or clearance of cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells, or a portion thereof, and methods of modulating antigen recognition, processing and/or presentation, as well as immune responses to material derived from cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells, or a portion thereof.
机译:本发明涉及结合树突细胞标记物Clec9A的蛋白质的鉴定。本发明提供了用于将治疗剂例如抗原靶向树突细胞的新化合物。还提供了调节对抗原的体液和/或T细胞介导的免疫反应的方法,将细胞毒剂递送到涉及患病状态的其树突状细胞的方法,调节被破坏的细胞的摄取和/或清除的方法。细胞膜,感染病原体的细胞,垂死的细胞或死细胞或其一部分,以及调节抗原识别,加工和/或呈递的方法以及对源自细胞膜破裂的细胞的材料的免疫应答的方法感染病原体,垂死细胞或死细胞或其一部分。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号